Kobo Biotech Ltd Financials
Company Logo

Kobo Biotech Ltd Financial Statement

Kobo Biotech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue0.02
Operating Expense0.34
Net Profit-1.33
Net Profit Margin-6650.00
Earning Per Share-0.56
EBIDTA-0.32
Effective Tax RateTBA

Kobo Biotech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue AnnualTBA
Operating Expenses Annual1.50
Operating Profit Annual-1.48
Interest Annual0.00
Depreciation4.07
Net Profit Annual-5.55
Tax AnnualTBA

Kobo Biotech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.13
Cash Flow from Operations0.87
Cash Flow from InvestingTBA
Cash Flow from Financing-0.87
Cash Flow at the End0.13

Kobo Biotech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Kobo Biotech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual37.59
Total Current Assets Annual37.74
Non Current Assets Annual37.59
Total Shareholders Funds Annual-127.98
Total Assets Annual75.33

Kobo Biotech Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Dec 7, 2024, Kobo Biotech Ltd has a market capitalization of 9.05 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Kobo Biotech Ltd is debt-free with a debt-to-equity ratio of -1.05.
In FY 2023 , Kobo Biotech Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Kobo Biotech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and NaN% annually, respectively..
Kobo Biotech Ltd's current PE ratio is -1.84.
Kobo Biotech Ltd's ROCE averaged -67.3% from the FY ending March 2022 to 2024, with a median of -72.7%. It peaked at -46.8% in March 2023, reflecting strong capital efficiency over the period..
Kobo Biotech Ltd's latest EBIT is Rs. -4.93 Cr, surpassing the average EBIT of Rs. -8.53 Cr over the 5 years..
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions